I
RPRX icon

InceptionR’s Royalty Pharma RPRX Stock Holding History

InceptionR’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$932K Sell
16,614
-27,943
-63% -$1.45M 0.23% 144
2026
Q1 		$2.14M Buy
44,557
+33,050
+287% +$1.45M 0.51% 11
2025
Q4 		$445K Buy
+11,507
New +$439K 0.12% 311

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

InceptionR's RPRX Position: Q2 2026 in Review

InceptionR reduced its Royalty Pharma (RPRX) stake by 63% in Q2 2026, selling an estimated $1.45M and leaving 16,614 shares worth $932K. The position accounts for 0.23% of the portfolio, ranked #144.

InceptionR first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.14M in Q1 2026. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • InceptionR held 16,614 shares of Royalty Pharma worth $932K as of Q2 2026.
  • InceptionR sold 27,943 Royalty Pharma shares in Q2 2026, an estimated $1.45M.
  • Royalty Pharma made up 0.23% of InceptionR's portfolio in Q2 2026, its #144 holding.
  • InceptionR first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • InceptionR's Royalty Pharma position peaked at $2.14M in Q1 2026.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.